NCT00345540: Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer |
|
|
| Completed | 2 | 15 | US | NOV-002, Oxidized Glutathione, Carboplatin, Paraplatin | Cellectar Biosciences, Inc., Massachusetts General Hospital, Dana-Farber Cancer Institute | Ovarian Cancer | 05/08 | 06/08 | | |